Author: Tasha

Comparative analysis of opicapone and entacapone in the management of motor fluctuations in patients with Parkinson’s disease, from clinical trials to healthcare resource usage Background…

Effect of Opicapone and Entacapone on Early Morning-OFF Pattern in Parkinson’s Disease Patients with Motor Fluctuations Objective: To evaluate the effect of opicapone (OPC) 50 mg…

Impact of IPX203 (CREXONT®) on Parkinson’s patients’ motor states upon awakening: analysis of patient diary data Objective: To evaluate “On” upon awakening in Parkinson’s disease patients…

Extended-release carbidopa-levodopa: How is CREXONT® different from RYTARY®? Objective: To compare two oral extended-release (ER) carbidopa-levodopa (CD-LD) formulations, CREXONT®  and RYTARY®

IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease Question  Can extended-release carbidopa-levodopa (IPX203) improve symptomatic control in patients with Parkinson disease…